MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
about
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cellsMarginal zone lymphoma-derived interfollicular diffuse large B-cell lymphoma harboring 20q12 chromosomal deletion and missense mutation of BIRC3 gene: a case report.B-myb is an essential regulator of hematopoietic stem cell and myeloid progenitor cell development.Identification of context-dependent expression quantitative trait loci in whole blood.Genetic characterization of acquired aplastic anemia by targeted sequencing.Deletion of Ptpn1 induces myeloproliferative neoplasm.
P2860
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@en
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@nl
type
label
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@en
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@nl
prefLabel
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@en
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@nl
P2093
P2860
P356
P1433
P1476
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.
@en
P2093
A Thomas Look
Carlos E Bueso-Ramos
Donna Neuberg
Kristen Stevenson
Lillian F Conover
Mignon L Loh
Outi Kilpivaara
Scott J Rodig
Stefan Heinrichs
Wen-Shu Wu
P2860
P304
P356
10.7554/ELIFE.00825
P407
P577
2013-07-16T00:00:00Z